Biologie trifft Mikroelektronik, das Motto des Institutes für Nano- und Biotechnologien (INB) an der Fachhochschule Aachen, unterstreicht die zunehmende Bedeutung interdisziplinär geprägter Forschungsaktivitäten. In der Nano- und Biotechnologie steckt außergewöhnliches Potenzial! Nicht zuletzt deshalb stellen sich Forscher aus unterschiedlichen Laboren der Herausforderung, in diesem Bereich gemeinsam zu forschen und Schnittstellen zu nutzen, um so bei der Gestaltung neuartiger Ideen und Produkte mitzuwirken, die zukünftig unser alltägliches Leben verändern werden. Als Partner profitieren Sie dabei von der Zusammenarbeit mit einem eingespielten fachübergreifenden Team als kompetentem Ansprechpartner. Neben einem breiten Methodenspektrum und einer weit gefächerten Infrastruktur besteht Expertise durch mehr als 40 langjährige wissenschaftliche Kooperationen zu nationalen und internationalen Hochschulen, Forschungseinrichtungen und Partnern aus der Industrie.
Silicon-based chemical sensors and biosensors, in terms of their micro- and nano-technological aspects, represent a challenging interdisciplinary area with a high potential for innovation. The importance of this topic is defined by the demand for miniaturization on the one hand, and the integration of sensors, actuators, and mechanical or fluidic elements onto one sensor chip and thus, the creation of miniaturized multifunctional analytical systems such as “lab-on-a-chip”, electronic tongue devices, µTAS (micro total analysis systems) or MEMS (micro-electro-mechanical system), on the other.To develop these sensor systems, a high standard of resources in both silicon- and thin-film processing is necessary, along with facilities to establish the characterization of micro- and nanostructures, especially at their interfaces and surfaces. In addition, tools for simulation and modeling in several dimensions are gaining importance in the development of micro- and nanosensors.
Besides fundamental research issues, chemo- and biosensorics together with chip technologies increasingly include application-oriented subjects. Here, the combination of micro- and nanostructures with stimulating functional materials offers a high potential for the development of intelligent sensor/actuator systems for numerous applications.
Research activities for medium- and long-term development include the following:
The laboratory for optical micro- and nanosystem technology combines different light-addressable technologies to create new types of sensors and actuators. On the sensor side, the main focus is on the light-addressable potentiometric sensor (LAPS), whereby changes in ion concentration and biomolecules could be determined on the sensor surface. Furthermore, light-responsive hydrogels are investigated, namely in terms of shrinking and swelling behavior. As a possible application this behaviour could be used in microfluidic channels as valves to control liquid flow streams.
Another field of interest is the light-addressability of living cells, using a light source to switch on or off certain metabolic pathways of cells. Also, light-addressable electrodes will be investigated to e.g., trigger catalytic processes in liquids such as the change of the pH value of the analyte.
Finally, the different areas of this research should be combined into a single system, comprising microfluidic channels, light-addressable cells and hydrogels as well as light-addressable electrodes and sensors. Such a system could be used to help current research investigations in medicine, pharmacy as well as basic research.
To support these set-ups, 3D-printing techniques are utilized to realize fast development and prototypes of new measurement set-ups, including microfluidics, configurations for measurement cells etc.
Surgery, radiotherapy and chemotherapy are the standard therapies for local tumor treatment and results commonly in a significant loss of quality of life and, moreover, in many cases effectiveness is limited. For example, in the case of prostate cancer, about one-third of patients will develop progressive or metastatic disease within 10 years after conventional treatment [Oefelein, M.G. et al., J Urol 158 (1997) 1460-1465]. In early metastatic disease androgen ablation is effective, but in most cases androgen-independent tumors develop. Subsequently, no effective treatment for androgen-independent prostate disease is available.
A promising possibility to render a therapeutic cancer treatment more effective could be the development of cancer-specific vaccines. The idea behind this approach is to activate the body's own defense system (especially, cytotoxic T lymphocytes) against cancer cells.
The activities of our laboratory “Applied Immunology” are focussing on the development and preclinical characterization of new therapeutic vaccines against cervical and prostate cancer.
Currently, the research is addressing on the following projects:
We develop and evaluate novel enzymes with the aim of direct technical application. One part of our approach is the efficient production of highly pure chiral compounds. Currently, the research is focused on the following topics:
Diacetyl and acetoin exhibit a butter-like flavor in alcoholic beverages, like beer and wine. These compounds are undesired in beers to give a clean, crisp taste, whereas higher concentrations of these compounds are desired in wines for a smoother taste and feel. Different novel acetoin reductases are recombinantly produced and investigated for the quantitative determination of diacetyl and acetoin in microbial fermentations.
Vicinal diketones, like diacetyl, are not only naturally produced in fermentation processes but can also yield chiral α-hydroxy ketones and vicinal diols by stepwise reduction. These are interesting synthons for complex chiral structures or monomers for mixed polymers with unique properties, respectively. As the chemical synthesis of enantiomerically pure α-hydroxy ketones or vicinal diols is difficult to achieve the direct, biocatalytic conversion of vicinal diketones with enzymes is advisable. Selected acetoin reductases/butanediol dehydrogenases are developed to achieve that aim.
Subtilisin protases are widely used in different industries, e.g. as an active component in laundry detergents. In this work, we aim to find even more suitable novel enzymes by cloning of new genes with relatively low homology to already known subtilisin genes and evaluation of the biochemical and performance parameters of the subsequent enzymes.
Over the past few years, the significance of Cell Culture Technology has increased considerably. It has become a key technology for the production of therapeutical proteins using biotechnology. Only mammalian cells can synthesize complex glycosylated proteins in an efficient manner. The expression of such proteins is industrially performed using recombinant hamster cells (CHO) or mouse cells (hybridomacells). For large-scale fermentation, suspension cultures in stirred tank fermenters are used in a scale up to 100 m3. The most relevant process technology is the fed-batch culture, using controlled feeding of the culture with media concentrates to prevent nutrient limitations.
Recent methods for process optimization are aimed at reducing the time of process development. For this purpose, fermentation data must be obtained even in the early stages of fermentation under controlled and reproducible conditions in order to allow a scale up of the process later on.
According to this, the research and development activities of the “Laboratory for Cell Culture Technology” are application-oriented and aimed at the development of:
Microorganisms, such as bacteria, archaea and fungi, are divers and exhibit remarkable metabolic variability. This makes microorganisms even more interesting as production organisms for valuable products. Since renewable raw materials are converted, they will make a decisive contribution to a sustainable economy, also referred to as bioeconomy. Industrial microbiology deals with the identification, evaluation, improvement and utilization of microorganisms in order to produce a wide range of products, including foods, beverages, platform chemicals, fuels, pharmaceuticals and enzymes. Bacillus species, mainly B. subtilis, B. licheniformis and B. amyloliquefaciens, are well-established production hosts for important technical enzymes on a very large scale. Nevertheless, it is important to identify and develop new production hosts to improve the availability of industrial enzymes, both novel and existent, in competitive yields and to open the process for new potential. On the other hand, genetic accessibility of already established production strains is often very limited. This leads to the need for better tools, in particular when the aim is to engineer the genome.
Currently, the research is focused on the following projects:
The field of semiconductor technology will in the future be increasingly dominated by nano-electronic structures due to progressive miniaturization. Modern information technology systems are based on extremely thin layers of materials and small structures just nanometers in size, where quantum-physical effects are used specifically to develop devices in an efficient way. With an atomic layer resolution, the semiconductor epitaxy is the key technology in the production of optoelectronic as well as nano-electronic structures. Examples of this are "Quantum Cascade Lasers", "Single Electron Devices ", "High Electron Mobility Transistors (HEMT)" and "Semiconductor Lasers", besides many other quantum devices.
Small structures or extremely thin layers will continue to increase in significance in the field of high-frequency engineering. As an example, "hot electrons" are used in III/V-heterostructure devices for the production of microwaves in the automotive industry; at present, quantum physical structures for "quantum computing" are being applied in the area of information technology. Moreover, quantum devices could play an important role in the future production of high frequencies in the THz area.
Future research in this field will undoubtedly include a clear application component besides pure fundamental research. In close cooperation with the Research Center Jülich, micro-and nano-electronic structures and systems will be produced and the qualities and prospects for future semiconductor devices are under examination. The following areas are of specific interest:
Development of micro-and nano-electronic semiconductor structures as well as electronic, quantum physical and high-frequency construction elements.
Further development of structuring methods in the micro- and nanometer area as well as the development of device processing as well as of micro-and nano-electronic structures for sensor applications.
Nanoparticles have become an integral part of current biomedical technology due to their unique physical properties. Silver or gold nanoparticles show so-called plasmon resonance and are already widely used in different sensor applications to detect specific target molecules. They can also be used as contrast agents in photoacoustic imaging and are suitable for cancer therapy using photothermia.
We are interested in the utilization of gold nanoparticles for in-vitro sensing applications because they can amplify single molecular vibrations by a factor of 1010 through the SERS (surface-enhanced Raman spectroscopy) effect. Thus, the detection of single molecules is enabled. For early cancer diagnosis from blood samples (liquid biopsy) the reliable detection of cancer-related biomarkers is necessary and a challenge for current research. In this context, we aim to develop tailor-made functionalized gold nanoparticles that form dimers with the respective biomarker, leading to an increase in the SERS intensity of a reporter molecule. The successful binding event of the biomarker is detected by a wavelength shift in the optical extinction spectrum (OES) and the increased intensity of the Raman signal. By this means, we want to develop a cheap and easy method to support early cancer diagnosis.
Another class of substances used in bioanalytics are magnetic iron oxide nanoparticles (IONPs), which are applied to separate and detect specific biomolecules and are suitable for in-vivo applications as MRI (magnetic resonance imaging) contrast agents or hyperthermia. In this context, we investigate the synthesis of monodisperse ligand stabilized and protein-conjugated magnetic nanoparticles for magnetic sensing applications (in collaboration with Prof. Dr. H.-J. Krause, FZJ).
FH Aachen Campus Jülich
Institut für Nano- und Biotechnologien
T +49.241.6009 53895